The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing engineered IgM antibodies for therapies.

Total Raised

$102 M

Rounds

1

Links

Verticals

Biotechnology
Medical
Therapeutics

Investment History

  1. Series C

    Jul 2019

    $102M

Team

Fred M. Schwarzer

Chief Executive Officer

Nelson Teng

Founder

Bruce Keyt

Chief Scientific Officer

Chris Takimoto

CMO